Hefty Wealth Partners’s Insys Therapeutics, Inc. INSY Stock Holding History

Hefty Wealth Partners’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-290	Closed	-$3K	–	270
2017 Q3	$3K	Buy	+290	New	+$2.99K	﹤0.01%	235

Other funds holding INSY

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hefty Wealth Partners's INSY Position: Q4 2017 in Review

Hefty Wealth Partners sold out of Insys Therapeutics, Inc. (INSY) in Q4 2017, closing a stake of 290 shares — an estimated $3K sold.

Hefty Wealth Partners first reported a position in INSY in Q3 2017 and held it in 1 quarter. The position peaked at $3K in Q3 2017. 112 funds tracked by Wall St. Rank hold INSY as of Q4 2017.

Hefty Wealth Partners reported no remaining Insys Therapeutics, Inc. position as of Q4 2017 after selling out during the quarter.
Hefty Wealth Partners sold 290 Insys Therapeutics, Inc. shares in Q4 2017, an estimated $3K.
Hefty Wealth Partners first reported a position in Insys Therapeutics, Inc. in Q3 2017 and held it in 1 quarter.
Hefty Wealth Partners's Insys Therapeutics, Inc. position peaked at $3K in Q3 2017.
112 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2017.

Based on Hefty Wealth Partners's 13F filing for Q4 2017, filed 3 Jan 2018.